Invitae Corp. (NVTA)

17.57
0.04 0.23
NYSE : Health Services
Prev Close 17.61
Open 17.78
Day Low/High 17.46 / 17.93
52 Wk Low/High 7.08 / 26.77
Volume 540.03K
Avg Volume 2.01M
Exchange NYSE
Shares Outstanding 89.84M
Market Cap 1.62B
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
Invitae To Announce First Quarter 2016 Financial Results And Host Conference Call On May 9, 2016

Invitae To Announce First Quarter 2016 Financial Results And Host Conference Call On May 9, 2016

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will report its first quarter 2016 financial results on Monday, May 9, 2016 and will host a conference call that day at 4:45...

Invitae Announces Medicare Reimbursement For Hereditary Breast Cancer-Related Disorders Under A New CPT Code For Multi-Gene Panels

Invitae Announces Medicare Reimbursement For Hereditary Breast Cancer-Related Disorders Under A New CPT Code For Multi-Gene Panels

Invitae Corporation (NYSE:NVTA), a genetic information company, announced that the Centers for Medicare and Medicaid Services (CMS) have begun providing payments for Invitae's multi-gene tests for hereditary breast...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CHMT, FMC, GHC, IBM, MGA, MUX, NVTA, PDVW, RAS Downgrades: SCMP, UEPS Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Invitae Presented Data At The NCCN Annual Conference On The Utility Of Multi-Gene Panels

Invitae Presented Data At The NCCN Annual Conference On The Utility Of Multi-Gene Panels

Invitae Corporation (NYSE:NVTA), a genetic information company, presented data on its guidelines-based genetic testing panels at the NCCN Annual Conference: Advancing the Standard of Cancer Care in Hollywood,...

Invitae Expands Its Comprehensive, High-quality, Affordable Genetic Tests (Graphic: Business Wire)

Invitae Expands Its Comprehensive, High-quality, Affordable Genetic Tests (Graphic: Business Wire)

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its genetic testing offering with hundreds of additional genes and expanded panels for neurology, pediatrics, and...

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AF, ALLE, LH, LLL, LMCA, MXIM, NVEE, TSRI, VEEV, VLP, WIFI, WPT Downgrades: HAWK, MS Initiations: AJX, BLCM, INOV, NVTA Read on to get TheStreet Quant Ratings' detailed report:

New Data On Rare Diseases Demonstrate Impact Of Delayed Diagnosis And Obstacles For Patients And Clinicians, Including Lack Of Information, Time To Diagnosis, And Accessibility Due To Cost. (Photo: Business Wire)

New Data On Rare Diseases Demonstrate Impact Of Delayed Diagnosis And Obstacles For Patients And Clinicians, Including Lack Of Information, Time To Diagnosis, And Accessibility Due To Cost. (Photo: Business Wire)

Invitae Corporation (NYSE:NVTA), a genetic information company, today presented data showing that both patients and clinicians in the rare disease community face significant obstacles navigating the diagnosis of...

Invitae Presents New Data Demonstrating High Concordance Of Variant Classifications For BRCA1/2 Across Major Clinical Testing Laboratories

Invitae Presents New Data Demonstrating High Concordance Of Variant Classifications For BRCA1/2 Across Major Clinical Testing Laboratories

Invitae Corporation (NYSE:NVTA), a genetic information company, today presented an important study at the 2016 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting,...

Commit To Purchase Invitae Corp At $7.50, Earn 25.8% Annualized Using Options

Commit To Purchase Invitae Corp At $7.50, Earn 25.8% Annualized Using Options

Investors eyeing a purchase of Invitae Corp shares, but tentative about paying the going market price of $9.03/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $7.50 strike, which has a bid at the time of this writing of $1.05.

Invitae To Present A Dozen Posters And Presentations At The 2016 American College Of Medical Genetics Annual Clinical Genetics Meeting

Invitae To Present A Dozen Posters And Presentations At The 2016 American College Of Medical Genetics Annual Clinical Genetics Meeting

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced it will be presenting a dozen posters and presentations at the 2016 American College of Medical Genetics (ACMG) Annual Clinical...

Invitae To Present At The Cowen And Company 36th Annual Health Care Conference

Invitae To Present At The Cowen And Company 36th Annual Health Care Conference

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that members of the company's management team will present at the Cowen and Company 36th Annual Health Care Conference on Monday,...

Invitae Announces Full Year 2015 Financial Results And 2016 Business Objectives

Invitae Announces Full Year 2015 Financial Results And 2016 Business Objectives

Invitae Corporation (NYSE: NVTA) today reported financial and operating results for the fourth quarter and full year ended December 31, 2015.

Invitae To Announce Fourth Quarter And Year-End 2015 Financial Results And Host Conference Call On February 9, 2016

Invitae To Announce Fourth Quarter And Year-End 2015 Financial Results And Host Conference Call On February 9, 2016

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it will report its fourth quarter and year-end 2015 financial results on Tuesday, February 9, 2016, and Invitae's management team...

Invitae Announces It Met Volume Guidance By Delivering Nearly 19,000 Billable Tests In 2015 And Sets Volume Guidance At 50,000-70,000 Billable Tests For 2016

Invitae Announces It Met Volume Guidance By Delivering Nearly 19,000 Billable Tests In 2015 And Sets Volume Guidance At 50,000-70,000 Billable Tests For 2016

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it met its volume guidance of 17,000-19,000 billable tests delivered in 2015, delivering nearly 19,000 billable tests for the...

5 Stocks Under $10 Setting Up to Trade Higher

5 Stocks Under $10 Setting Up to Trade Higher

Here's how to trade five low-priced stocks poised to move higher.

Invitae Announces Expansion Of Its Epilepsy Test Menu

Invitae Announces Expansion Of Its Epilepsy Test Menu

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it has expanded its epilepsy testing menu, now offering an extensive panel with more than 100 carefully curated genes that...

Invitae Announces Expansion Of Hereditary Cancer Testing Menu

Invitae Announces Expansion Of Hereditary Cancer Testing Menu

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced that it has expanded its hereditary cancer genetic testing menu, now offering an even more comprehensive testing menu that covers all...

Invitae Announces Third Quarter 2015 Financial Results And Raises 2015 Volume Guidance

Invitae Announces Third Quarter 2015 Financial Results And Raises 2015 Volume Guidance

Invitae Corporation (NYSE: NVTA) today reported financial and operating results for the third quarter ended September 30, 2015.

Christine Gorjanc Joins Invitae's Board Of Directors (Photo: Business Wire)

Christine Gorjanc Joins Invitae's Board Of Directors (Photo: Business Wire)

Invitae Corporation (NYSE:NVTA), a genetic information company, today announced the appointment of Christine M.

Invitae To Provide Testing For Sudden Death In The Young (SDY) Case Registry To Advance Understanding Of Sudden Death In The Young

Invitae To Provide Testing For Sudden Death In The Young (SDY) Case Registry To Advance Understanding Of Sudden Death In The Young

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it has entered into a collaboration with the Sudden Death in the Young (SDY) Case Registry, the first ever active surveillance...

Invitae To Announce Third Quarter 2015 Financial Results And Host Conference Call On November 5, 2015

Invitae To Announce Third Quarter 2015 Financial Results And Host Conference Call On November 5, 2015

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will report its third quarter 2015 financial results on Thursday, November 5, 2015, and will host a conference call that day...

Invitae Expands Its Cardiology Offering To Provide More Comprehensive Testing For Patients And Their Families

Invitae Expands Its Cardiology Offering To Provide More Comprehensive Testing For Patients And Their Families

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced the expansion of its cardiology offering, including more than 30 cardiovascular test panels for arrhythmias, cardiomyopathies,...

Invitae Expands Its Hereditary Cancer Offering

Invitae Expands Its Hereditary Cancer Offering

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it is releasing the next generation of comprehensive cancer panels, providing broader panels and new testing categories.

Invitae Expands Its Neuromuscular Offering With Broad, Affordable Panels And New Testing Categories For Patients

Invitae Expands Its Neuromuscular Offering With Broad, Affordable Panels And New Testing Categories For Patients

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced it now offers genetic testing for neuromuscular diseases, including Duchenne/Becker muscular dystrophy, dystonia, and pediatric...

Invitae Expands Its Offering For Rare Disease And Pediatric Conditions With Broader, Affordable Genetic Tests

Invitae Expands Its Offering For Rare Disease And Pediatric Conditions With Broader, Affordable Genetic Tests

nvitae Corporation (NYSE: NVTA), a genetic information company, today announced that it has started to expand its offering of genetic tests for rare diseases and pediatric conditions, providing broader panels and...

Invitae Expands Test Menu To Include Hundreds Of New Genes, Dozens Of New Test Panels For Cancer, Cardiology, Neuromuscular, Pediatrics, And Rare Disorders

Invitae Expands Test Menu To Include Hundreds Of New Genes, Dozens Of New Test Panels For Cancer, Cardiology, Neuromuscular, Pediatrics, And Rare Disorders

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it has more than doubled the size of its genetic testing platform to include more than 600 genes and will release the new content...

Invitae To Host Investor Conference Call On October 7, 2015 To Discuss Expanded Genetic Testing Menu

Invitae To Host Investor Conference Call On October 7, 2015 To Discuss Expanded Genetic Testing Menu

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will host an investor conference call on Wednesday, October 7 at 4:30 p.

Relative Strength Alert For Invitae

Relative Strength Alert For Invitae

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Invitae Announces New Education Program To Accelerate The Use Of Family History And Increase Awareness Of Genetic Testing

Invitae Announces New Education Program To Accelerate The Use Of Family History And Increase Awareness Of Genetic Testing

A new survey released today shows 73 percent of Americans are aware of genetic testing for hereditary cancers - a significant increase over just a few years ago.

Invitae To Present At The 2015 Morgan Stanley Global Healthcare Conference

Invitae To Present At The 2015 Morgan Stanley Global Healthcare Conference

Invitae Corporation (NYSE:NVTA) today announced that members of the company's management team will present at the 2015 Morgan Stanley Global Healthcare Conference on Friday, September 18, 2015 at approximately 8:45...

TheStreet Quant Rating: D (Sell)